BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 23896359)

  • 1. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes.
    Browne JA; Adib F; Brown TE; Novicoff WM
    J Arthroplasty; 2013 Sep; 28(8 Suppl):34-7. PubMed ID: 23896359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008.
    Kirksey M; Chiu YL; Ma Y; Della Valle AG; Poultsides L; Gerner P; Memtsoudis SG
    Anesth Analg; 2012 Aug; 115(2):321-7. PubMed ID: 22652311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty.
    Jans Ø; Jørgensen C; Kehlet H; Johansson PI;
    Transfusion; 2014 Mar; 54(3):717-26. PubMed ID: 23829298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital volume and inpatient mortality outcomes of total hip arthroplasty in the United States.
    Doro C; Dimick J; Wainess R; Upchurch G; Urquhart A
    J Arthroplasty; 2006 Sep; 21(6 Suppl 2):10-6. PubMed ID: 16950056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
    Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
    J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a bipolar sealer in total hip arthroplasty: medical resource use and costs using a hospital administrative database.
    Ackerman SJ; Tapia CI; Baik R; Pivec R; Mont MA
    Orthopedics; 2014 May; 37(5):e472-81. PubMed ID: 24810825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.
    Saleh A; Small T; Chandran Pillai AL; Schiltz NK; Klika AK; Barsoum WK
    J Bone Joint Surg Am; 2014 Sep; 96(18):e155. PubMed ID: 25232085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in allogeneic blood transfusion usage in total hip arthroplasty patients: National Inpatient Sample 2009 to 2013.
    Gwam CU; Mistry JB; Etcheson JI; George NE; Connors G; Thomas M; Adamu H; Patel NG; Delanois RE
    Hip Int; 2018 Jul; 28(4):382-390. PubMed ID: 29218687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion practice in hip arthroplasty--a nationwide study.
    Jans Ø; Kehlet H; Hussain Z; Johansson PI
    Vox Sang; 2011 May; 100(4):374-80. PubMed ID: 21029109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient factors affecting autologous and allogeneic blood transfusion rates in total hip arthroplasty.
    Marx RG; Wotherspoon S; Stephens D; Davey JR
    Am J Orthop (Belle Mead NJ); 2001 Dec; 30(12):867-71. PubMed ID: 11771798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The second Austrian benchmark study for blood use in elective surgery: results and practice change.
    Gombotz H; Rehak PH; Shander A; Hofmann A
    Transfusion; 2014 Oct; 54(10 Pt 2):2646-57. PubMed ID: 24805865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Trends in Blood Utilization After Revision Hip and Knee Arthroplasty.
    Burnett RA; Bedard NA; DeMik DE; Gao Y; Liu SS; Callaghan JJ
    J Arthroplasty; 2017 Dec; 32(12):3693-3697. PubMed ID: 28951054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty.
    Graves A; Yates P; Hofmann AO; Farmer S; Ferrari P
    Nephrology (Carlton); 2014 Jul; 19(7):404-9. PubMed ID: 24655225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Parkinson Disease Increase the Risk of Perioperative Complications After Total Hip Arthroplasty? A Nationwide Database Study.
    Newman JM; Sodhi N; Dalton SE; Khlopas A; Newman RP; Higuera CA; Mont MA
    J Arthroplasty; 2018 Jul; 33(7S):S162-S166. PubMed ID: 29402715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends in the utilization of blood transfusions in total hip and knee arthroplasty.
    Yoshihara H; Yoneoka D
    J Arthroplasty; 2014 Oct; 29(10):1932-7. PubMed ID: 24890994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates.
    Hart A; Khalil JA; Carli A; Huk O; Zukor D; Antoniou J
    J Bone Joint Surg Am; 2014 Dec; 96(23):1945-51. PubMed ID: 25471908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement.
    Memtsoudis SG; Ma Y; Chiu YL; Walz JM; Voswinckel R; Mazumdar M
    Anesth Analg; 2010 Nov; 111(5):1110-6. PubMed ID: 20841415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion practice in total hip arthroplasty in Danish departments of orthopaedic surgery].
    Pedersen AB; Mehnert F; Overgaard S; Møller B; Johnsen SP
    Ugeskr Laeger; 2009 Mar; 171(12):973-7. PubMed ID: 19284915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing transfusion practice in total hip arthroplasty: observational study of the reduction of blood use over 6 years.
    Robinson PM; Obi N; Harrison T; Jeffery J
    Orthopedics; 2012 Nov; 35(11):e1586-91. PubMed ID: 23127447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Use of Blood Transfusion in Primary Total Hip and Knee Arthroplasties.
    Menendez ME; Lu N; Huybrechts KF; Ring D; Barnes CL; Ladha K; Bateman BT
    J Arthroplasty; 2016 Dec; 31(12):2757-2763.e2. PubMed ID: 27325367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.